CompletedEUCTR 2010-019369-27

A Phase II randomized, double-blind, parallel-group, multi-site, placebo controlled fixed-dose study of Echinaceae angustifoliae root dry extract in 24 outpatients with generalized anxiety disorder...

This historical record does not confirm current site availability.

Historical research recordHungary

The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Hungary
Study phase: Phase 2

Study clarity

Study information

Study start dateNot clearly listed

Recruitment status: Completed
Enrollment listed in the registry: 30
Sponsor: Anxiofit Ltd.
Sponsor type: Other organization
Study type: Biological
Intervention type: BIOLOGICAL
Study phase: Phase 2
Locations: Hungary
Age range: Not clearly listed
Official registry ID: EUCTR 2010-019369-27
Official title: Show the full official title
A Phase II randomized, double-blind, parallel-group, multi-site, placebo controlled fixed-dose study of Echinaceae angustifoliae root dry extract in 24 outpatients with generalized anxiety disorder...

Looking for a study you can join?

Explore recruiting studies

Get this study by email

Recruitment & locations

Completed

Hungary

Registry details

Historical country statuses

Hungary — Completed

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Anxiofit Ltd.

Want to explore more studies?

Explore studies